Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
about
Serotonergic neuronal sprouting as a potential mechanism of recovery in multiple sclerosis.Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis.Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields.Amine metabolites in ventricular cerebrospinal fluid in coma.Action of cyproheptadine in spastic paraparetic patientsCSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields.Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders.Magnetic fields normalize visual evoked potentials and brainstem auditory evoked potentials in multiple sclerosis.Long term beneficial effects of weak electromagnetic fields in multiple sclerosis.Tryptophan availability and the susceptibility to stress in multiple sclerosis: a hypothesis.The pineal gland, cataplexy, and multiple sclerosis.Premenstrual exacerbation of symptoms in multiple sclerosis is attenuated by treatment with weak electromagnetic fields.Resolution of sleep paralysis by weak electromagnetic fields in a patient with multiple sclerosis.The pineal gland in multiple sclerosis.Coexisting bipolar affective disorder and multiple sclerosis: the role of the pineal gland.The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link.Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields.Resolution of longstanding symptoms of multiple sclerosis by application of picoTesla range magnetic fields.Serotonergic neuronal atrophy with synaptic inactivation, not axonal degeneration, are the main hallmarks of multiple sclerosis.Treatment with electromagnetic fields improves dual-task performance (talking while walking) in multiple sclerosis.Weak electromagnetic fields restore dream recall in patients with multiple sclerosis.Rapid normalization of visual evoked potentials by picoTesla range magnetic fields in chronic progressive multiple sclerosis.Resolution of partial cataplexy in multiple sclerosis by treatment with weak electromagnetic fields.Multiple sclerosis: relationship between seasonal variations of relapse and age of onset.Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis.Application of weak electromagnetic fields facilitates sensory-motor integration in patients with multiple sclerosis.Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields.Improvement by picoTesla range magnetic fields of perceptual-motor performance and visual memory in a patient with chronic progressive multiple sclerosis.
P2860
Q33841831-84ABC151-059E-4CD7-B4EE-C45A5FE22758Q35223138-125BCD2F-0E65-4F09-9F70-65EE33A1D7DEQ36681597-CE0C8E57-635B-4C8B-A384-6E762A7EA05BQ36995256-F9A08225-F2E5-422C-A635-D9C6CF487283Q37026420-2F96D19B-2205-4D9A-9D1B-0EA9C1E00267Q37057057-46A83D7C-44AB-4DA3-BE62-287618DA52FBQ39494291-0B94EADA-5996-45A0-94DD-987BB835F9B8Q40690936-93FE2EC3-575D-46CE-9DCD-899E8A2FDDFBQ40690942-4F1F7DCB-D0D2-40C3-AFF7-546AB4587E3DQ41069606-79017B7E-8AFA-4C7F-BD44-808CA32169D3Q41128782-18FA39A2-92E6-4C80-8A3B-CF0D16749EEEQ41163471-4D1CB53A-D411-47DF-891F-450FA7E8CA5BQ41163507-00E807E2-0EDE-4218-8639-297848BBF14EQ41628283-DA90D56A-6EE5-4E21-B79A-73FFECAE015CQ45095011-8FA8B14F-BC4C-4FCB-A494-203FA1AA7CC2Q46688212-80B34710-686F-4DAB-A7B0-2AAD5EB623F2Q48114673-81558524-8711-4BAB-9F5D-32AA664AE05AQ48223458-B726B31B-3FB0-4FD1-B451-267F186EC910Q48280329-FAF78043-3300-48F5-B752-350B10BA302CQ48333540-44EF45C1-0230-44C5-8AC3-480E0757B9B6Q48498380-D977BA0D-B51D-4714-B102-86530A49F932Q48821860-C6268A08-7ECC-4357-A048-C1ECF8319CE8Q48837691-2DD8DEB8-9ACE-4916-B4E0-212988788DD1Q49140568-50E92A43-CD75-49EB-8FB5-60F914F65F18Q50607498-FB2A5D40-E410-4C07-AF2F-364A117BB080Q52000784-ABF42220-8253-485C-82E2-52D1DE71050BQ52009105-BC6F4597-47BC-45CD-BDA0-14617A4A6D7EQ52056215-968B7348-D64B-4DF6-AC8D-00351BFF48D0Q52214843-348EDAB3-7B0E-4724-ACE3-E3074137A337
P2860
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1977
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
@en
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
@nl
type
label
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
@en
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
@nl
prefLabel
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
@en
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
@nl
P2093
P2860
P356
P1476
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
@en
P2093
P2860
P304
P356
10.1136/JNNP.40.8.741
P407
P577
1977-08-01T00:00:00Z